224 related articles for article (PubMed ID: 38374034)
21. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study.
Bouzid D; Visseaux B; Kassasseya C; Daoud A; Fémy F; Hermand C; Truchot J; Beaune S; Javaud N; Peyrony O; Chauvin A; Vaittinada Ayar P; Bourg A; Riou B; Marot S; Bloom B; Cachanado M; Simon T; Freund Y;
Ann Intern Med; 2022 Jun; 175(6):831-837. PubMed ID: 35286147
[TBL] [Abstract][Full Text] [Related]
23. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
[TBL] [Abstract][Full Text] [Related]
24. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
25. Clinical utilization of artificial intelligence-based COVID-19 pneumonia quantification using chest computed tomography - a multicenter retrospective cohort study in Japan.
Tanaka H; Maetani T; Chubachi S; Tanabe N; Shiraishi Y; Asakura T; Namkoong H; Shimada T; Azekawa S; Otake S; Nakagawara K; Fukushima T; Watase M; Terai H; Sasaki M; Ueda S; Kato Y; Harada N; Suzuki S; Yoshida S; Tateno H; Yamada Y; Jinzaki M; Hirai T; Okada Y; Koike R; Ishii M; Hasegawa N; Kimura A; Imoto S; Miyano S; Ogawa S; Kanai T; Fukunaga K
Respir Res; 2023 Oct; 24(1):241. PubMed ID: 37798709
[TBL] [Abstract][Full Text] [Related]
26. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
27. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics of the severe acute respiratory syndrome coronavirus 2 omicron variant compared with the delta variant: a retrospective case-control study of 318 outpatients from a single sight institute in Japan.
Suzuki K; Ichikawa T; Suzuki S; Tanino Y; Kakinoki Y
PeerJ; 2022; 10():e13762. PubMed ID: 35935257
[TBL] [Abstract][Full Text] [Related]
29. Pre-Delta, Delta, and Omicron Periods of the Coronavirus Disease 2019 (COVID-19) Pandemic and Health Outcomes During Delivery Hospitalization.
Carlson J; Simeone RM; Ellington S; Galang R; DeSisto CL; Fleming-Dutra K; Riley L; Meaney-Delman D; Tong VT
Obstet Gynecol; 2024 Jan; 143(1):131-138. PubMed ID: 37917932
[TBL] [Abstract][Full Text] [Related]
30. Association between vaccination status and COVID-19-related health outcomes among community-dwelling COVID-19 patients in Nara, Japan.
Tomioka K; Uno K; Yamada M
Environ Health Prev Med; 2023; 28():7. PubMed ID: 36682815
[TBL] [Abstract][Full Text] [Related]
31. Severe COVID-19 outcomes in pediatrics: An observational cohort analysis comparing Alpha, Delta, and Omicron variants.
Bahl A; Mielke N; Johnson S; Desai A; Qu L
Lancet Reg Health Am; 2023 Feb; 18():100405. PubMed ID: 36474521
[TBL] [Abstract][Full Text] [Related]
32. Adverse outcomes of SARS-CoV-2 infection with delta and omicron variants in vaccinated versus unvaccinated US veterans: retrospective cohort study.
Bohnert AS; Kumbier K; Rowneki M; Gupta A; Bajema K; Hynes DM; Viglianti E; O'Hare AM; Osborne T; Boyko EJ; Young-Xu Y; Iwashyna TJ; Maciejewski M; Schildhouse R; Dimcheff D; Ioannou GN
BMJ; 2023 May; 381():e074521. PubMed ID: 37220941
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019-positive patients.
Hu FH; Jia YJ; Zhao DY; Fu XL; Zhang WQ; Tang W; Hu SQ; Wu H; Ge MW; Du W; Shen WQ; Zhu B; Chen HL
Clin Microbiol Infect; 2023 Jul; 29(7):835-844. PubMed ID: 36934872
[TBL] [Abstract][Full Text] [Related]
34. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
35. Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of Age.
Shi HJ; Yang J; Eom JS; Ko JH; Peck KR; Kim UJ; Jung SI; Kim S; Seok H; Hyun M; Kim HA; Kim B; Joo EJ; Cheong HS; Jun CH; Wi YM; Kim J; Kym S; Lim S; Park Y
J Korean Med Sci; 2023 Jul; 38(28):e217. PubMed ID: 37463688
[TBL] [Abstract][Full Text] [Related]
36. Risk of severe COVID-19 in unvaccinated patients during the period from wild-type to Omicron variant: real-world evidence from Japan.
Tomioka K; Uno K; Yamada M
Environ Health Prev Med; 2024; 29():10. PubMed ID: 38447970
[TBL] [Abstract][Full Text] [Related]
37. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
Wolter N; Jassat W; Walaza S; Welch R; Moultrie H; Groome M; Amoako DG; Everatt J; Bhiman JN; Scheepers C; Tebeila N; Chiwandire N; du Plessis M; Govender N; Ismail A; Glass A; Mlisana K; Stevens W; Treurnicht FK; Makatini Z; Hsiao NY; Parboosing R; Wadula J; Hussey H; Davies MA; Boulle A; von Gottberg A; Cohen C
Lancet; 2022 Jan; 399(10323):437-446. PubMed ID: 35065011
[TBL] [Abstract][Full Text] [Related]
38. Severe infection due to the SARS-CoV-2 coronavirus: Experience of a tertiary hospital with COVID-19 patients during the 2020 pandemic.
Rodríguez A; Moreno G; Gómez J; Carbonell R; Picó-Plana E; Benavent Bofill C; Sánchez Parrilla R; Trefler S; Esteve Pitarch E; Canadell L; Teixido X; Claverias L; Bodí M; ; ; ; ; ; ;
Med Intensiva (Engl Ed); 2020 Dec; 44(9):525-533. PubMed ID: 32654921
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and clinical effectiveness of COVID-19 vaccination in hospitalized patients in Omicron-dominated epidemic wave - a nationwide study in Japan.
Tanaka H; Chubachi S; Asakura T; Namkoong H; Azekawa S; Otake S; Nakagawara K; Fukushima T; Lee H; Watase M; Sakurai K; Kusumoto T; Masaki K; Kamata H; Ishii M; Hasegawa N; Okada Y; Koike R; Kitagawa Y; Kimura A; Imoto S; Miyano S; Ogawa S; Kanai T; Fukunaga K
Int J Infect Dis; 2023 Jul; 132():84-88. PubMed ID: 37086866
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 infection in children evaluated in an ambulatory setting during Delta and Omicron time periods.
Smith H; Mahon A; Moss A; Rao S
J Med Virol; 2023 Jan; 95(1):e28318. PubMed ID: 36397139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
